Imunon, Inc.

Imunon, Inc. - Enterprise Valueverified

CLSN

Price:

$1.9466

Market Cap:

$5.71M

Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon,...[Read more]

Industry

Biotechnology

IPO Date

1993-10-27

Stock Exchange

NASDAQ

Ticker

CLSN

The Enterprise Value as of September 2026 (TTM) for Imunon, Inc. (CLSN) is 6.70M

According to Imunon, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.70M. This represents a change of -17.51% compared to the average of 8.12M of the last 4 quarters.

Imunon, Inc. (CLSN) Historical Enterprise Value (quarterly & annually)

How has CLSN Enterprise Value performed in the past?

The mean historical Enterprise Value of Imunon, Inc. over the last ten years is 11.66M. The current 6.70M Enterprise Value has changed 5.64% with respect to the historical average. Over the past ten years (40 quarters), CLSN's Enterprise Value was at its highest in in the September 2016 quarter at 510.07M. The Enterprise Value was at its lowest in in the September 2022 quarter at -6859784.80.

Quarterly (TTM)
Annual

Average

11.66M

Median

8.37M

Minimum

-9582146.50

Maximum

47.39M

Imunon, Inc. (CLSN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Imunon, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 174.14%

Maximum Annual Enterprise Value = 47.39M

Minimum Annual Increase = -163.34%

Minimum Annual Enterprise Value = -9582146.50

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025315.63K-95.97%
20247.84M174.14%
20232.86M-51.23%
20225.86M-161.19%
2021-9582146.50-163.34%
202015.13M-68.08%
201947.39M92.86%
201824.57M84.90%
201713.29M49.48%
20168.89M-80.38%

Imunon, Inc. (CLSN) Average Enterprise Value

How has CLSN Enterprise Value performed in the past?

The current Enterprise Value of Imunon, Inc. (CLSN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

3.67M

5-year avg

1.46M

10-year avg

11.66M

Imunon, Inc. (CLSN) Enterprise Value vs. Peers

How is CLSN’s Enterprise Value compared to its peers?

Imunon, Inc.’s Enterprise Value is less than Celyad Oncology S.A. (9.03M), less than Kineta, Inc. (7.04M), greater than Reunion Neuroscience Inc. (-7193195.00), greater than SQZ Biotechnologies Company (-28631213.00), greater than Alpha Compute Corp (1.84M), greater than Axcella Health Inc. (-2482600.00), greater than Notable Labs, Ltd. (-7381410.00), less than TuHURA Biosciences, Inc. (133.14M), less than Talphera, Inc. (59.46M), less than Anew Medical, Inc. (16.87M),

CompanyEnterprise ValueMarket cap
9.03M$14.24M
7.04M$7.05M
-7193195.00$13.12M
-28631213.00$707.79K
1.84M$666.63K
-2482600.00$12.50M
-7381410.00$2.39M
133.14M$133.73M
59.46M$60.20M
16.87M$15.44M

Build a custom stock screener for Imunon, Inc. (CLSN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imunon, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Imunon, Inc. (CLSN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Imunon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Imunon, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Imunon, Inc. (CLSN)?

What is the 3-year average Enterprise Value for Imunon, Inc. (CLSN)?

What is the 5-year average Enterprise Value for Imunon, Inc. (CLSN)?

How does the current Enterprise Value for Imunon, Inc. (CLSN) compare to its historical average?